comparemela.com

Latest Breaking News On - Mybiotics pharma ltd - Page 1 : comparemela.com

Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy

Share this article REHOVOT and JERUSALEM , Israel, April 6, 2021 /PRNewswire/ MyBiotics Pharma Ltd. http://biomx.com/, a microbiome therapeutics company, and Hadasit Medical Research Services and Development Ltd., the technology transfer office of Hadassah Medical Center, announced today that they have entered into a research collaboration and licensing agreement for the identification of microbiome-based therapeutics that will enhance the response to and reduce adverse effects of anti-PD-1 and anti-PD-L1 in melanoma patients. The collaboration will combine Hadassah s knowhow and expertise in immunotherapy treatment of melanoma patients with MyBiotics proprietary microbiome technologies enabling development of novel therapeutics. The two-year joint research project will be conducted by researchers from MyBiotics together with a team of researchers at Hadassah Cancer Research Institute headed by Prof. Michal Lotem, MD., Head of the Center for Melanoma and Cancer Immunotherapy,

MyBiotics, Hadassah to study impact of microbiome on cancer therapies

Shoshanna Solomon is The Times of Israel s Startups and Business reporter A 3D illustrative image of rod-shaped bacteria and cocci in the human microbiome (Dr Microbe; iStock by Getty Images) MyBiotics Pharma Ltd. said Tuesday it will work with Hadasit Medical Research Services and Development Ltd., the technology transfer arm of Hadassah Medical Center, to identify microbiome-based therapies to improve the impact of cancer immunotherapies in melanoma patients. MyBiotics has developed technologies to culture, ferment and deliver highly stable and diverse bacterial communities that can target different sites across the human body to restore the microbiome equilibrium. The collaboration will combine Hadassah’s knowhow and expertise in immunotherapy treatment for melanoma patients with MyBiotics’ microbiome technologies to enable development of new drugs, the companies said in a statement.

Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy

Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy

Hadassah and MyBiotics to Collaborate for the Discovery of Microbiome-Based Therapy for Improving Cancer Immunotherapy
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.